Opioids part1-2010
The Challenge of Addiction and Hepatitis C (pps)
Treatment and access to treatment in low and middle income countries Adeeba Kamarulzaman University of Malaya Kuala Lumpur, Malaysia ANRS-NIDA Joint Satellite.
Recent HCV treatment developments: In pursuit of perfectovir Professor Greg Dore Kirby Institute, UNSW Australia; & St Vincent’s Hospital, Sydney.
HCV-HBV co-infection in Russian Federation Chumakov Institute of Poliomyelitis and Viral Encephalitis, Moscow Karen Kyuregyan VIII Annual Conference of.
Epidemiology and Control Programs for HBV Infection. Yousef Qari, MD, FRCP(C), ABIM Gastoenterologist King Abdulaziz University Hospital.
Hepatitis C in Pakistan Rashid A. Chotani Assistant Professor & Director, The Global Infectious Disease Surveillance & Alert System The Johns Hopkins Bloomberg.
Introducing Harm Reduction in Mauritius Emphasizing on the lack of services for Young People Who Inject Drugs Guffran Rostom Head of Department Prevention,
Washington D.C., USA, 22-27 July 2012 HCV genotype and HBV co-infection associate with HCV clearance in HIV- positive subjects Yuan Dong,
Renal Transplantation for HIV/HCV Co-infected Patients Solid Organ Transplantation and People With HIV: Ethics and Policy Conference David Oldach & Robert.
Washington D.C., USA, 22-27 July 2012 Human rights as a key component of harm reduction strategy targeting people using drugs in Morocco.
Methamphetamine use in the Czech Republic History of methamphetamine 1950s – Misuse of psychostimulant medicines (Psychoton) 1960s – Misuse phenmetrazine.